BILLERICA, Mass.,
May 23, 2016/PRNewswire/ --
Bruker Corporation(NASDAQ: BRKR) today announced that its shareholders have elected Dr.
Cynthia Friendas a new member of the Board of Directors, effective
May 20, 2016.
Dr. Friend currently serves as Director of the
Rowland Instituteat
Harvard University. She also serves as Director of the
DoE Energy Frontier Research Center for Sustainable Catalysisat
Harvard. In 2011-2012, Dr. Friend was the Associate Director of the
SLAC National Accelerator Laboratory. From 2001-2011, she was the Associate Director of the Materials Research Science and Engineering Center, from 2004-2007, she was the Chair of the
Chemistry and Chemical Biology Department, and from 2002-2005, she was Associate Dean of the Faculty of Arts & Sciences, all at
Harvard University.
Dr. Friend became the Theodore Williams Richards Professor of Chemistry in 1998 and a Professor of Materials Science in 2002 at
Harvard University. Since joining the
Harvard Department of Chemistryin 1982, she has received numerous awards for her scientific research, and has served on a number of research and scientific advisory boards and panels. Dr. Friend holds a Ph.D. in Chemistry from the
University of California, Berkeley.
Frank Laukien, the President and CEO of
Bruker, stated: "It is my great pleasure to welcome Cynthia to
Bruker'sBoard of Directors. Her experience with science policy, research priorities and strategy development will be very valuable to Bruker. In addition, her insights into scientific trends and emerging applications will help us prioritize and direct our research and development investments, and grow with new opportunities and in new markets."
"I am looking forward to serve on the Board of Directors of
Bruker Corporation- a leader in the development of scientific instrumentation and analytical methods," said
Cynthia Friend. "It will be a pleasure to work with the
Brukerteam to foster additional innovation in the future."
About
Bruker Corporation
For more than 50 years,
Bruker越是加大使科学家能够取得突破eries and develop new applications that improve the quality of human life.
Bruker'shigh-performance scientific research instruments and high-value analytical solutions enable scientists to explore life and materials at molecular, cellular and microscopic levels.
In close cooperation with our customers,
Brukeris enabling innovation, productivity and customer success in life science molecular research, in applied and pharma applications, and in microscopy, nano-analysis and industrial applications, as well as in cell biology, preclinical imaging, clinical research, microbiology and molecular diagnostics. For more information, please visit://www.energie2point0.com.
Photo -http://photos.prnewswire.com/prnh/20160523/370750
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/dr-cynthia-friend-joins-bruker-board-of-directors-300273062.html
SOURCE
Bruker Corporation
Joshua Young, Vice President, Investor Relations and Corporate Development, Bruker Corporation, T: 1 (978) 667 - 9580, ext. 1479, joshua.young@Bruker.com